Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer
5048.6000 -152.60 (-2.93%)
NSE Apr 25, 2025 13:37 PM
Volume: 47,436
 

logo
Alkem Laboratories Ltd.
08 Feb 2025
5048.60
-2.93%
buy
by BOB Capital Markets Ltd.
Target: 4527 | Target met
BOB Capital Markets Ltd.
Domestic sales were 6% below our estimates mainly due to slower recovery in the acute therapies and no price hike in NLEM portfolio
 
Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended
Market trades lower, PB Fintech invests Rs 539.4 crore in its arm, PB Healthcare Services
Trendlyne Marketwatch | 25 Apr 2025, 01:37PM
RARE Enterprises reduces holding in edible oils maker, Singhania cuts stakes in 2 firms to below 1%
Rakesh Jhunjhunwala and Associates | 24 Apr 2025, 05:45PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
| 02 Jul 2021